Background: Parkinson's disease (PD) is divided into postural instability gait difficulty (PIGD) and tremor-dominant (TD) subtypes. Increasing evidence has suggested that the GABAergic neurotransmitter system is involved in the pathogenesis of PD. Purpose: To evaluate the differences of GABA levels between PD motor subtypes using MEscher-GArwood Point Resolved Spectroscopy (MEGA-PRESS). Study Type: Cohort.: SUBJECTS: PD patients were classified into PIGD (n 5 13) and TD groups (n 5 9); 16 age-and sex-matched healthy controls were also recruited. All subjects were right-handed. Sequence: All subjects underwent an magnetic resonance spectroscopy scan including MEGA-PRESS at 3.0T. ASSESSMENT: The detected GABA signal also contains signal from macromolecules (MM) and homocarnosine, so it is referred to as GABA1. GABA 1 levels and Creatine (Cr) levels were quantified in the left basal ganglia (BG) using Gannet 2.0 by Tao Gong. Statistical Tests: Differences in GABA 1 levels between the three groups were analyzed using analysis of covariance. The relationship between GABA levels and a unified PD rating scale (UPDRS) was also analyzed. Results: GABA 1 levels were significantly lower in left BG regions of PD patients compared with healthy controls (P < 0.001). In PD patients, the GABA concentration was lower in the TD group than the PIGD group (P 5 0.019). Cr levels in PIGD and TD were lower than controls (P 5 0.020; P 5 0.002). A significant negative correlation was found in PIGD between GABA levels and UPDRS (r 5 20.572, P 5 0.041), while no correlation was found in TD (r 5 20.339, P 5 0.372).
P
arkinson's disease (PD) can be divided into two motor subtypes, 1 postural instability gait difficulty (PIGD) and tremor-dominant (TD), depending on whether tremor or balance and gait disturbances are the most pronounced symptoms. Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the human brain. Increasing evidence has suggested that the GABAergic neurotransmitter system is involved in the pathogenesis of PD. 
H-MRS) is a noninvasive technique that permits measurements
of neurometabolites in the healthy or diseased human brain in vivo, including various degenerative diseases. [3] [4] [5] [6] The low concentration of GABA and the presence of overlapping signals from more concentrated metabolites render GABA measurements ambiguous using conventional 1 H-MRS at 3.0T. 7 As a result, a spectral editing technique, MEscher-GArwood Point Resolved Spectroscopy (MEGA-PRESS 8 , is widely used to remove overlapping signals, allowing observations of GABA levels in healthy and diseased patients.
The basal ganglia play a major role in the regulation of human movement: the major projection from the substantia nigra is to nuclei of the basal ganglia; and the basal ganglia circuitry processes the signals that flow from the cortex, allowing the correct execution of voluntary movements, as dramatically manifest in PD. 12 In basal ganglia, the majority of neurons use GABA as the neurotransmitter and has inhibitory effects on their targets. Previous studies have demonstrated altered GABA levels in the basal ganglia of PD patients compared to healthy volunteers. 13, 14 Thus, the aims of this study were to: 1) evaluate differences in GABA levels between motor subtypes of PD in basal ganglia using MEGA-PRESS, and 2) determine the relationship between GABA levels and the Unified Parkinson's Disease Rating Scale (UPDRS) in PD patients.
Materials And Methods

Subjects
Twenty-three patients with a clinical diagnosis of idiopathic PD (14 women and 9 men aged 45-79 years) according to the UK PD Brain Bank criteria, 15 and 16 age-and sex-matched healthy controls (9 women and 7 men aged 46-70 years) were recruited in this study (Table 1 ). All subjects were right-handed. The local Ethics Board approved this study and participants provided written informed consent before study initiation. All the patients were assessed by a neurologist (Y.X.) with 6 years' experience in diagnosing movement disorders. The Hoehn and Yahr (H-Y) stage and the motor part (part III) of the UPDRS were used to assess the severity of illness during an "off" phase (at least 12 hours off medicine).
We The TD subtype was defined as the ratios of 1.5 or more; whereas PIGD subtype as the ratios 1.0 and indeterminate subtype as the ratios between 1.0 and 1.5. In addition, patients with a zero in the average global "PIGD" score were classified as TD; patients with a zero in the mean global tremor score were classified as PIGD. Subjects with an indeterminate subtype were excluded from further analysis.
MRI/MRS Study Protocol
All the data were acquired using a 3.0T MR scanner (Philips Achieva TX, Best, The Netherlands) with an 8-channel phasedarray head coil. Three-dimensional turbo field echo T 1 -weighted images were acquired using the following parameters: repetition time / echo time (TR/TE) 5 8. ; flip angle 5 88. The T 1 images were used for MRS voxel placement in the region of the left BG and tissue segmentation. The MRS voxel was placed on axial images between the Sylvian fissure and the lateral ventricle, with the anterior border aligned with the medial midpoint of caudate nucleus, the sagittal superior border along the floor of the lateral ventricle body. Coronal and sagittal images were used to adjust the position of the region of interest (ROI) in order Significant differences between groups were tested by analysis of covariance, adjusting for GM / (GM 1 WM1CSF) with P < 0.05 accepted as significant.
to maximize inclusion of basal ganglia structures while avoiding the lateral ventricle, as shown in Fig. 1 MEGA-PRESS allows the GABA signal to be separated from other overlapping signals by making use of the J-coupling between GABA's C-3 protons at 1.89 ppm and the C-4 protons at 3.01 ppm. During the scan, two spectra were obtained: every even acquisition (edit-OFF) is a regular PRESS sequence, whereas during odd acquisitions (edit-ON) a narrow-bandwidth (88 Hz FWHM) 14-msec sinc-Gaussian RF pulse was applied to the resonance peak at 1.89 ppm. The majority of peaks in the ON and OFF spectra, including overlapping Cr and choline (Cho) signals, are unaffected by the editing pulses, so subtraction of the OFF from the ON spectra removes them, retaining a well-defined GABA signal at 3.01 ppm. Unsuppressed water signals were also recorded with the same parameters (except with four signal averages) as an internal concentration reference.
MRS Data Processing and Quantification
The GABA signal detected at 3 ppm also contains signal from macromolecules (MM) and homocarnosine 17 ; hence, the detected signal is referred to as GABA 1 rather than GABA. GABA 1 levels were quantified in the BG (Fig. 1a,b ) using the MatLab-based (MathWorks, Natick, MA) analysis toolkit, Gannet 2.0 18 (Fig. 2) .
Gannet has two modules, GannetLoad and GannetFit, capable of processing MEGA-PRESS data and provide quantitative metrics of the GABA peak, as shown in previous studies. 16, 19 Only spectra with a relative fitting error (FitError) of GABA 1 generated by GannetFit below 10% were included in the final statistical analysis. Water-scaled Cr concentrations can be estimated in institutional units (i.u.) from metabolite peak amplitudes according to the following formula: defined as the number of protons contributing to the water signal and the Cr signal at 3.0 ppm. Segmentation of T 1 -weighted images was performed using SPM8 (Fig. 1c) . The GM fractions (GM / (GM 1 WM 1 CSF)) were estimated as the ratio of GM volume to the sum of GM, White matter (WM) volumes and cerebrospinal fluid (CSF) in the ROIs.
Statistical Analysis
The results are presented as mean 6 standard deviation (SD). Statistical analysis was performed to determine differences of GABA 1 levels and Cr levels among PIGD, TD, and controls using analysis of covariance (ANCOVA), adjusting for GM fractions and least significant difference (LSD) tests. The differences in sex, age, GABA 1 fitting errors, and GM fractions between the aforementioned three groups were determined using analysis of variance (ANOVA). Student's t-test was used to compare the disease duration, H-Y stage, and UPDRS between PIGD and TD. Pearson correlation coefficients were used to assess the presence of linear associations between GABA 1 levels and UPDRS. P < 0.05 was considered significant. Statistical analyses were conducted using SPSS 22.0 (Chicago, IL).
Results
The ANOVA revealed no statistical differences in age (P 5 0.847) and sex distribution (P 5 0.123) (Table 1) between the three groups. No statistical differences were found in duration (P 5 0.582), H-Y stage (P 5 0.206), and UPDRS (P 5 0.214) between the PIGD and TD groups.
No differences between PIGD, TD, and controls were observed in voxel segmentation (P 5 0.284, see Table 1 ). GABA 1 levels were significantly lower in BG regions of PD patients compared with healthy controls (P < 0.001). In PD patients, the GABA 1 concentration was lower in the TD group than PIGD group (P 5 0.019) (Fig. 3) . Table 1 shows that the Cr levels in the PIGD and TD groups were lower than healthy controls (P 5 0.020 and 0.002, respectively). The Cr level in the TD group was not significantly lower than in the PIGD group (P 5 0.440). There was a negative correlation in whole PD patients between GABA 1 levels and UPDRS (r 5 20.425, P 5 0.048). A significant negative correlation was found in PIGD between GABA 1 levels and UPDRS (r 5 20.572, P 5 0.041), while no significant correlation was observed in TD (r 5 20.339, P 5 0.372), as shown in Fig. 4 .
Discussion
This study has shown that GABA 1 levels were reduced in the left BG region of PD patients compared with age-and sex-matched healthy controls. We further demonstrated significant differences in GABA 1 levels between the major motor subtypes of PD and GABA 1 correlation with UPDRS. Basal ganglia Cr levels were also reduced in PD patients compared with healthy controls.
In previous human studies, GABA levels in the striatum or putamen have been reported to be either reduced, 22 unaltered, 14 or elevated 13, 23 in PD compared with healthy controls. Similarly, either elevated BG GABA levels 24, 25 or reduced left striatum GABA levels 26 have been reported in animal studies. Our study showed reduced GABA 1 levels in a BG region, which includes the striatum. Relative to healthy controls, the differing GABA 1 levels in PD patients between our study and the literature could be due to several reasons. First, a larger volume of interest (VOI; including striatum, globus pallidus, part of thalamus, and other gray-and whitematter structures) was chosen for our study (3 3 3 3 2 cm 3 ) because of the different data acquisition strategy. Indeed, thalamic GABA levels in Refs. 22 and 14 are significantly reduced.
Second, there are differences between methodologies-our study is closest in methodology to Ref. 14. And in this study, water was used as a reference to quantify GABA levels rather than Cr. 24, 27 Third, cohort factors, such as demographics, inclusion criteria, and effects of PD treatment can influence GABA levels. 2 Lastly, there is a concern that high CSF content in PD BG voxels might contribute to lower GABA levels because of brain atrophy. However, the voxel CSF fraction is small (6%) in all groups and group differences in CSF fraction are small and nonsignificant. Additionally, we performed CSF correction on the water-referenced GABA 1 measurements to mitigate such effects (which does not substantially change the statistical outcomes of the study).
The reduced GABA levels in our study might indicate that the pathogenesis of PD may be related to GABAergic neuronal loss or dysfunction. These results are in line with the GABA-collapse hypothesis recently proposed by Blaszczyk. 28, 29 PD is a severe multisystemic neurodegenerative disorder of the nervous system, whose clinical symptoms reflect the progression of the most advanced GABA pathology.
We further demonstrated significant differences in GABA 1 levels between the major motor subtypes of PD. PIGD progresses more rapidly than TD 30, 31 ; however, we found that the BG GABA 1 levels in TD were significantly lower than PIGD. This may indicate that TD and PIGD differ in terms of central pathophysiological mechanisms. One previous study found no significant relationships between GABA levels in pons or putamen regions (using a 7T MR scanner) and the UPDRS. 13 In our study, however, we found a significant negative relationship between BG GABA 1 levels and UPDRS of PD patients, indicating that altered GABA levels relate to symptom type and severity. The significant relationship between GABA levels and UPDRS was mainly driven by the PIGD group, probably because of the smaller number of PD patients in the TD group or limited range of GABA values; consequently, there was reduced statistical power to detect a correlation. Altered Cr levels have previously been found in the putamen portion of BG, while other regions showed no changes. 32, 33 It has also been demonstrated that Cr can be elevated in PD patients after acute administration of L-DOPA. 34 Given that Cr levels in PD patients were significantly different from healthy controls, in agreement with previous studies, 34, 35 Cr may not be an appropriate choice for an internal reference, especially for the calculation of GABA levels in the BG region of PDs. 34, 36 The study has several limitations, including study design and data acquisition strategy. First, the sample size in each group was rather small for a clinical study of this kind, especially for the TD group. Therefore, these results should be viewed as preliminary, and a larger sample size should be recruited to confirm the results. Second, it is always possible that group differences in metabolite levels arise as a result of relaxation differences (either in the metabolite or water signals) between groups. Future research estimating relaxation values (T 1 and T 2 ) in subjects with PD would be beneficial. Third, the VOI was relatively large (3 3 3 3 2 cm   3 ), comprising striatum, thalamus, and globus pallidus structures. The larger VOI was necessary to increase the signal-to-noise ratio of the GABA signal (due to the low intensity of GABA MRS signals available at 3T) and remains a limitation of the MEGA-PRESS technique. 7 The large VOI reduces the specificity of results; therefore, the results of our study may not be representative of individual structures of BG. Fourth, the GABA 1 levels detected by MEGA-PRESS represent GABA plus coedited macromolecules (MM) and homocarnosine. New methods for detecting "pure GABA" 37 should be employed for future studies of PD patients, but remain extremely sensitive to experimental instability. 38 Fifth, only left BG regions were studied, basing that decision on handedness (all subjects were right-handed), rather than considering laterality with respect to the predominantly affected side. This remains a concern in spite of one previous study suggesting that there are no differences of major metabolites in PD patients between contralateral and ipsilateral sides. 34 We demonstrated, in a preliminary fashion, differences in GABA 1 between PIGD and TD, and a correlation between GABA levels and UPDRS in PIGD/TD patients. Low BG GABA 1 levels in PD patients, and differences between PIGD/ TD patients, suggest that GABAergic dysfunction may play an important role in the pathogenesis of PD.
